6-Phenyl-2,3-dihydroimidazo[2,1-b]thiazole-5-carbaldehyde, 95.0%, 5g

3-(3-nitrophenyl)-4H-1,2,4-triazole, 1g

(S)-Methyl 2-amino-3-(tert-butoxycarbonylamino)-3-methylbutanoate, 95.0%, 1g

2-(2-Bromo-5-fluoro-phenoxy)acetonitrile, 97.0%, 250mg

Methyl 2-benzamidobenzoate, 95+%, 100mg

2-Methyl-1,2,3,4-tetrahydroisoquinolin-5-ol, 97.0%, 250mg

4-Phenylthiosemicarbazide, 98.0%, 250g

3-(2-methylphenyl)prop-2-ynoic acid, 95.0%, 100mg

4-Bromo-3-hydroxybenzonitrile, 95.0%, 25g

2'-Bromo-2,7-di-tert-butyl-9,9'-spirobi[fluorene], 97%, 100g

1-(4-(Trifluoromethoxy)phenyl)piperazine hydrochloride, 95%, 5g

(3aS,6aS)-1-methyloctahydropyrrolo[3,4-b]pyrrole, 95.0%, 5g

Plan stress-free PLPOLi 100x/0.80 IOS objective for iScope incident polarization, no cover glass correction. Working distance 2 mm